Nextleaf Solutions Ltd (OILS)

Nextleaf Solutions Reports Fiscal Q2 2026 ResultsJune 1, 2026 9:30 AM
NewsfileVancouver, British Columbia--(Newsfile Corp. - June 1, 2026) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) ("Nextleaf" or the "Company") a multi-patented Canadian cannabis processor, announced financial results for Q2 FY2026 (ended March 31, 2026), with gross revenue of $3,338,310 and gross profit of $914,536 (38% gross margin).The quarter reflects deliberate investment in commercial infrastructure, including a national sales agency, qualified export ready platform, and a second licensed processing site, amidst a backdrop of industry-wide pricing compression.Margin & Profitability $3,338,310 gross revenueGross Profit of $914,536, on Net Revenue of $2,406,388Gross margin held at 38.0% in Q2 FY2026 vs 38.3% in Q2 FY2025 despite continued industry-wide pricing compression underscoring the resilience of Nextleaf's manufacturing model and cost discipline.Net loss of $646,277, reflecting deliberate investment in commercial infrastructure and platform readiness ahead of anticipated FY2026 revenue contribution.Adjusted EBITDA of $107,129 for the six months ended March 31, 2026.Excise duties of $931,921 paid to the Canada Revenue Agency, representing 28% of gross revenue.Revenue & Market PositionFirst-ever international export revenue: $322,358 in FY2026 (vs $0 FY2025), generated entirely from white label shipments to Australia, establishing Nextleaf as a qualified, and validated, export-ready processor.Glacial Gold® held a leadership position, ranked #2 for national market share in the ingestible-capsule subcategory at approximately 19% of retail dollars in Q2 FY2026. Glacial Gold THC 10 Softgels (100-count) ranked among Canada's top two best-selling softgel SKUs by retail revenue.1Revenue from bulk distillate grew 23.6% year-over-year to $429,621 (Q2 FY2025: $347,580), reflecting accelerating demand for Nextleaf's B2B ingredient platform amidst increasing pricing pressure in branded CPG.Expanded distribution partnerships into Manitoba, Saskatchewan, new listings in Québec (via Québec Craft Cannabis), and achieving national retail sales coverage through the Company's partnership with Kindred Canada.1. Source: Turff (brand.turff.ai), Canadian cannabis retail measurement.FY2026 OutlookNextleaf enters the third quarter (April to June 2026) focused on continued implementation of the Company's FY2026 Strategic Objectives.Micro-Processing License of Nextleaf Distribution, the Company's second site of operations. Allowing the Company to scale domestic and export-ready operations while maintaining quality oversight, resource utilization, and operational efficiency.Advancing the Company's export-ready platform by completing subsequent shipments and due diligence with additional commercial partners in expanded jurisdictions.Secure toll processing agreements to supplement top line revenue and bolster bottom line growth in the Company's bulk ingredient business.Hiring and onboarding sales leadership role to execute domestic CPG business objectives.Expanded listings from brand High Plains Cannabis. A formulation-first, value-engineered assortment built around high-demand product attributes and utilization of the Company's in-house ingredient portfolio.Management CommentaryManagement views Q2 as an investment quarter that positions Nextleaf for the domestic portfolio and distribution reset, and international expansion now underway."Our Q2 financial results reflect intentional, and disciplined execution in a highly competitive market," said Emma Andrews, CEO. "Despite continued pricing compression, we invested in infrastructure that strengthens our position as a capital-efficient, qualified export-ready, cannabis processing leader."Share IssuanceAs part of the Company's compensation and retention strategy, Nextleaf issued 266,667 common shares at a price per share $0.06 for aggregate proceeds of $16,000 to certain employees of the Company. This is to align employee interests with long-term shareholder value. When issued, the shares will be subject to a four month hold period in accordance with the policies of the Canadian Securities Exchange.About Nextleaf SolutionsNextleaf® is an innovation-driven life sciences company and licensed cannabis processor with a portfolio of consumer brands, market-validated cannabis derivative products, and high-potency bulk ingredients. Nextleaf's multi-patented, automated extraction and distillation technology sets the standard for processing cannabis at scale.The Company's scalable, asset-light platform is built on intellectual property, patented technology and API, enabling total-quality oversight in the development and commercialization of differentiated, value-driven, cannabinoid-based products for domestic and international markets.Nextleaf's portfolio includes 75+ global patents for the extraction and refinement of cannabinoid-based ingredients, alongside category-leading flagship brand Glacial Gold, High Plains Cannabis, and Yard Cannabis. The Company maintains an average of 35+ active SKUs across 5 categories of consumption.On behalf of the Board of Directors of the Company,
Emma Andrews, CEOFor More Information
Email: investors@nextleafsolutions.com
Follow Nextleaf Solutions on LinkedIn
Learn More: www.nextleafsolutions.com
Nextleaf trades as OILS on the Canadian Securities Exchange, OILFF on the OTCQB Market in the United States, and L0MA on the Frankfurt Stock Exchange.Non-GAAP MeasuresThis press release contains references to certain non-GAAP financial measures, including EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin. These measures are not recognized measures under International Financial Reporting Standards ("IFRS") and do not have a standardized meaning prescribed by IFRS. The Company's method of calculating these non-GAAP measures may differ from the methods used by other issuers and, accordingly, may not be directly comparable to similar measures presented by other issuers.Management believes these non-GAAP measures provide useful supplemental information to investors regarding the Company's operating performance because they exclude certain non-cash items, finance costs, income taxes, and other items that management does not consider reflective of ongoing operating performance. These non-GAAP measures should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS.A reconciliation of Net Loss (the most directly comparable IFRS measure) to Adjusted EBITDA is presented above. For additional information regarding non-GAAP financial measures, please refer to the Company's Management's Discussion and Analysis for Q1 2026, available on SEDAR+ at www.sedarplus.ca.Forward-Looking StatementsThis press release contains certain "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of applicable Canadian securities laws. Forward-looking statements include statements regarding the Company's expectations for future financial performance, operational outlook, product launches, margin trajectory, capacity utilization, capital allocation, and strategic priorities. These statements are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied by such statements.Material factors and assumptions that could cause actual results to differ materially include, without limitation: changes in the regulatory environment for cannabis in Canada; competition; changes in consumer preferences; the Company's ability to execute on its commercial strategy; access to capital; and the other risk factors described in the Company's Annual Information Form and Management's Discussion and Analysis filed on SEDAR+. The Company undertakes no obligation to update or revise any forward-looking statements except as required by applicable securities laws. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/299620 Original: Nextleaf Solutions Reports Fiscal Q2 2026 Results

Nextleaf Reports AGM Results and Expands Industry Leadership Through CCBCMay 6, 2026 9:00 AM
NewsfileVancouver, British Columbia--(Newsfile Corp. - May 6, 2026) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), a multi-patented life science company and Canadian cannabis processor announces the results of its annual general meeting of shareholders (the "Meeting") held on April 30, 2026, in Vancouver, British Columbia, and provides an update on its continued engagement in industry advocacy initiatives supporting the advancement of British Columbia's cannabis sector.To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/5347/296103_c054c0ee246258c3_001full.jpgAt the Meeting, shareholders approved all matters put forward by management, including:The re-election of Emma Andrews, Sam Kassem, Fred Bonner, and Sherry Boodram as directors of the Company for the ensuing year; andThe re-appointment of Davidson & Company LLP as the Company's auditor for the ensuing year, with remuneration to be determined by the board of directors.The Company's board continues to reflect a balance of operational leadership and independent oversight, supporting disciplined governance and long-term value creation.Industry Engagement and AdvocacyNextleaf has joined the Cannabis Cultivators of British Columbia ("CCBC"), a leading provincial industry association representing Health Canada licence holders, including cultivators and processors. In addition to corporate membership, CEO Emma Andrews has been appointed to the CCBC Board of Directors and will contribute to a special committee focused on advancing opportunities for British Columbia-based operators in global cannabis markets.Through its participation in CCBC, the Company supports collaborative dialogue with provincial stakeholders, including government and regulatory bodies, aimed at enabling sustainable growth and improving the competitiveness of BC's cannabis sector. Areas of focus include export development, regulatory alignment, and fostering a resilient, responsible supply chain."Nextleaf has always taken a long-term view of building a sustainable business within a highly regulated environment," said Emma Andrews, CEO of Nextleaf Solutions. "We see industry collaboration and thoughtful policy engagement as critical components of that work, particularly as Canadian operators look to participate more meaningfully in global markets."With a focus on capital efficiency, scalable technology, and standardized cannabinoid ingredients, Nextleaf continues to align its operations with evolving regulatory frameworks and demand for consistency, quality, and dose control.About Nextleaf Solutions Ltd.Nextleaf® is an innovation-driven life sciences company and licensed cannabis processor with a portfolio of consumer brands, market-validated cannabis derivative products, and high-potency bulk ingredients. Nextleaf's multi-patented, automated extraction and distillation technology sets the standard for processing cannabis at scale.The Company's scalable, asset-light platform is built on intellectual property, patented technology and API, enabling total-quality oversight in the development and commercialization of differentiated, value-driven, cannabinoid-based products for domestic and international markets.Nextleaf's portfolio includes 75+ global patents for the extraction and refinement of cannabinoid-based ingredients, alongside category-leading flagship brand Glacial Gold, High Plains Cannabis, and Yard Cannabis. The Company maintains an average of 35+ active SKUs across 5 categories of consumption.On behalf of the Board of Directors of the Company, Emma Andrews, CEOContact: investors@nextleafsolutions.com Follow Nextleaf Solutions on LinkedIn Learn More: www.nextleafsolutions.comNextleaf trades as OILS on the Canadian Securities Exchange, OILFF on the OTCQB Market in the United States, and L0MA on the Frankfurt Stock Exchange.Disclaimers and Disclosure Statements:Certain statements contained in this press release constitute "forward-looking statements" within the meaning of applicable securities laws. All statements other than statements of historical fact contained in this press release, including, without limitation, statements regarding the Company's anticipated delivery of its products to provincial markets across Canada and those regarding the Company's strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words "believe", "expect", "aim", "intend", "plan", "continue", "will", "may", "would", "anticipate", "estimate", "forecast", "predict", "project", "seek", "should" or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company's expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to the risk factors discussed in the Company's MD&A for the most recent fiscal period. Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information.Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law. The Canadian Securities Exchange has not reviewed or approved the contents of this press release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/296103 Original: Nextleaf Reports AGM Results and Expands Industry Leadership Through CCBC

Nextleaf Advances Capex-Light Model with New Micro-Processing Site Licence, Supporting Revenue Growth and Margin ExpansionApril 20, 2026 9:00 AM
NewsfileVancouver, British Columbia--(Newsfile Corp. - April 20, 2026) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), a multi-patented life science company and Canadian cannabis processor, is pleased to announce it has been granted a Health Canada Micro-Processing Licence for its second site of operations, Nextleaf Distribution.The issuance of this licence marks a key milestone in the Company's capex-light expansion strategy strengthening its position as a pure-play extraction and global processing platform delivering scalable, capital efficient, profitable growth.To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/5347/293358_83735edf7448d924_001full.jpgScaling Infrastructure with Capital DisciplineNextleaf Distribution, a 2,500 sq. ft. facility located near the Company's primary processing site in Coquitlam, British Columbia, is now licensed to conduct select activities under Health Canada's micro-processing framework.This licensing structure enables capacity expansion with minimal capex, allowing the Company to scale their domestic and export-ready operations while maintaining quality oversight, resource utilization, and operational efficiency. The facility is expected to support packaging, distribution, and select manufacturing functions.Focused Operating Model Driving Margin ExpansionNextleaf's asset light operating model leverages high-margin activities in the value-driven segment of the supply chain:Scalable Extraction & Distillation Technology: Globally patented, automated, closed-loop system achieving industry leading throughput and economics.Formulation & API Development: Standardized cannabinoid inputs for therapeutic, derivative products and consumer packaged goods.Brand Portfolio: Glacial Gold, Yard Cannabis, and High Plains capturing a range of segments, channels and markets.Commercial Partners Program: Bulk ingredients, toll processing, and white label manufacturing. The addition of a second licensed site enables greater specialization across facilities, supporting the Company's continued capacity utilization, reduced unit costs, and the growth of a higher-margin product mix.Management Commentary"The issuance of our micro-processing licence is a meaningful step in scaling our platform with discipline while maintaining a focus on being a total quality producer," said Vipin Vikraman, VP Operations of Nextleaf Solutions."The additional licensed space allows us to streamline aspects of fulfilment and distribution and supports greater agility throughout the product lifecycle. This expansion aligns with our focus on total quality oversight while building an operational model that is efficient and aligned with long-term margin expansion," shares Vikraman.Strategic OutlookThe addition of Nextleaf Distribution as a licensed micro-processing site under the Company's asset-light model, is expected to:Increase operational flexibility and agility, accelerating speed-to-market and responding quickly to consumer trendsSupport international brand expansion without compromising on domestic fulfilmentEnable scalable growth through continued capital discipline, while maximizing capacity utilizationThis milestone signals Nextleaf's continued evolution into a globally scalable, sustainably profitable, export-ready platform for cannabinoid-based consumer products and ingredients.Share IssuanceAs part of the Company's compensation and retention strategy, Nextleaf will issue 166,667 common shares at a price per share $0.06 for aggregate proceeds of $10,000. This is to align employee interests with long-term shareholder value.About Nextleaf Solutions Ltd.Nextleaf® is an innovation-driven life sciences company and licensed cannabis processor with a portfolio of consumer brands, market-validated cannabis derivative products, and high-potency bulk ingredients. Nextleaf's multi-patented, automated extraction and distillation technology sets the standard for processing cannabis at scale.The Company's scalable, asset-light platform is built on intellectual property, patented technology and API, enabling total-quality oversight in the development and commercialization of differentiated, value-driven, cannabinoid-based products for domestic and international markets.Nextleaf's portfolio includes 75+ global patents for the extraction and refinement of cannabinoid-based ingredients, alongside category-leading flagship brand Glacial Gold, High Plains Cannabis, and Yard Cannabis. The Company maintains an average of 35+ active SKU's across 5 categories of consumption.On behalf of the Board of Directors of the Company,
Emma Andrews, CEO Contact: investors@nextleafsolutions.com Follow Nextleaf Solutions on LinkedIn Learn More: www.nextleafsolutions.comNextleaf trades as OILS on the Canadian Securities Exchange, OILFF on the OTCQB Market in the United States, and L0MA on the Frankfurt Stock Exchange. Disclaimers and Disclosure Statements: Certain statements contained in this press release constitute "forward-looking statements" within the meaning of applicable securities laws. All statements other than statements of historical fact contained in this press release, including, without limitation, statements regarding the Company's anticipated delivery of its products to provincial markets across Canada and those regarding the Company's strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words "believe", "expect", "aim", "intend", "plan", "continue", "will", "may", "would", "anticipate", "estimate", "forecast", "predict", "project", "seek", "should" or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company's expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to the risk factors discussed in the Company's MD&A for the most recent fiscal period. Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law. The Canadian Securities Exchange has not reviewed or approved the contents of this press release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/293358
Original: Nextleaf Advances Capex-Light Model with New Micro-Processing Site Licence, Supporting Revenue Growth and Margin Expansion

Nextleaf Solutions Scales up CPG Brand Growth with an Enhanced National Commercial PlatformFebruary 19, 2026 9:00 AM
NewsfileVancouver, British Columbia--(Newsfile Corp. - February 19, 2026) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), a multi-patented life science company and Canadian cannabis processor announced strategic enhancements to its commercial infrastructure, including appointment of Kindred Canada as its national sales agency partner, and the addition of enhanced distribution partners serving Manitoba and Saskatchewan. These initiatives are designed to support scalable, margin-focused growth in its Canadian consumer-packaged goods (CPG) business.Nextleaf Scales Up CPG Brand Growth with Enhanced National Commercial PlatformTo view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/5347/284504_16c5f0e9548f8955_001full.jpgNational Sales Representation UpdateNextleaf is pleased to announce the recent appointment of Kindred Canada as its national sales agency partner. After a year of margin expansion, supply chain optimization and portfolio rationalization, the Company is turning its attention to driving scalable revenue and strengthening infrastructure. The transition to a national sales representation model was implemented between November 2025 and January 2026, marking a shift from a previously regionalized approach."Centralizing our national sales platform with a proven, performance-driven partner accelerates our ability to convert operational discipline into sustainable top-line growth through stronger retail partnerships, expanded listings, and consistent execution across provinces," said Emma Andrews, CEO of Nextleaf Solutions.Kindred Canada will support national sales execution across Nextleaf's brand portfolio, including reinforcing Glacial Gold's position as a category leader in cannabis wellness, advancing key account penetration, and supporting the national launch of the Company's newest recreational brand, Yard Cannabis ("Yard")."With Kindred's established retail relationships and national reach, we expect to improve distribution, increase velocity, deepen key account engagement, and enhance execution at the store level, especially in previously underserved markets" Comments Curtis Mackenzie, EVP and General Manager at Kindred Canada.The partnership supports Nextleaf's broader mission as a total quality producer, and vision to build a resilient, scalable Canadian CPG platform anchored in disciplined brand management, operational efficiency, and market optimization.Enhanced Distribution: Manitoba and SaskatchewanNextleaf is pleased to announce expanded provincial distribution relationships in Manitoba and Saskatchewan to enhance its brand strategy and accelerate growth in underserved markets.In Saskatchewan, Open Fields Distribution (OFD) is now a distribution partner for all branded products from the Company including Glacial Gold, Yard, and High Plains cannabis. OFD provides access to a collective network of stores, offering enhanced retail penetration and brand visibility within its network.In Manitoba, the Company recently expanded its 3PL infrastructure to include Open Fields Manitoba who will provide last-mile delivery for all products under the Company's latest brand, Yard cannabis, to provincially licensed retailers starting in March. This is in addition to all Glacial Gold and High Plains cannabis products currently available province-wide through existing partners, Lynx distribution.Provincial sales representation will be integrated through Kindred Canada, the Company's national sales agency. All regional initiatives are intended to improve listing velocity, strengthen in-market execution, and ensure greater consistency in how the Company's portfolio is represented and supported at retail across Canada.Share IssuanceAs part of the Company's compensation and retention strategy, Nextleaf will issue 955,556 common shares at a price per share $0.05 for aggregate proceeds of $47,778. This is to align employee interests with long-term shareholder value.About Nextleaf Solutions Ltd.Nextleaf® is a Canadian, federally licensed cannabis processor and life science company, delivering a portfolio of high purity cannabinoid ingredients and branded derivative products at scale.As a total quality producer, Nextleaf maintains end-to-end controls and oversight across sourcing, extraction, distillation, formulation, and finished goods through a multi-patented, highly automated, closed-loop system. Nextleaf holds 19 U.S. patents and over 75 patents globally covering advanced cannabinoid processing, including extraction, distillation, and acetylation.Nextleaf's house of brands includes a range of value-driven and soft-premium offerings through category-leading flagship brand Glacial Gold, High Plains Cannabis, and recently launched Yard Cannabis. Distributed coast-to-coast across medical and recreational channels, with an emerging niche amongst wellness consumers, Nextleaf's portfolio includes GMP-compliant and export-ready pharma-grade ingredients and products.On behalf of the Board of Directors of the Company,
Emma Andrews, CEO Contact: investors@nextleafsolutions.com Follow Nextleaf Solutions on LinkedIn Learn More: www.nextleafsolutions.comNextleaf trades as OILS on the Canadian Securities Exchange, OILFF on the OTCQB Market in the United States, and L0MA on the Frankfurt Stock Exchange. About Kindred? Kindred Partners Inc. is a wholly owned Canadian subsidiary of Breakthru Beverage Group representing a diverse portfolio of specialty cannabis products to the Canadian recreational market. This dedicated cannabis sales brokerage operates independently from?its sister company, Breakthru Beverage Canada, a leading Canadian beverage alcohol broker. For more information, please visit www.kindredcanada.ca. Disclaimers and Disclosure Statements: Certain statements contained in this press release constitute "forward-looking statements" within the meaning of applicable securities laws. All statements other than statements of historical fact contained in this press release, including, without limitation, statements regarding the Company's anticipated delivery of its products to provincial markets across Canada and those regarding the Company's strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words "believe", "expect", "aim", "intend", "plan", "continue", "will", "may", "would", "anticipate", "estimate", "forecast", "predict", "project", "seek", "should" or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company's expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to the risk factors discussed in the Company's MD&A for the most recent fiscal period. Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law. The Canadian Securities Exchange has not reviewed or approved the contents of this press release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/284504
Original: Nextleaf Solutions Scales up CPG Brand Growth with an Enhanced National Commercial Platform

Nextleaf Solutions Completes Initial Softgel Shipment to Australia and Announces Global Expansion of Commercial Partners Program(TM)February 13, 2026 9:00 AM
NewsfileVancouver, British Columbia--(Newsfile Corp. - February 13, 2026) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), a multi-patented life science company and Canadian cannabis processor, is pleased to announce expansion of its Commercial Partners ProgramTM to support global market growth, through completion of an initial softgel shipment to Australia.Nextleaf Announces Initial Softgel Shipment to AustraliaIn January 2026 Nextleaf served as exporter of record for a commercial shipment of 756,000 cannabis softgels to a white-label client in Australia."By leveraging our core capabilities, purchasing scale, lean infrastructure, and established regulatory expertise, Nextleaf streamlined the process and reinforced our role as a disciplined, capital-efficient partner within the global medical cannabis supply chain," shared Vipin Vikraman, VP Operations at Nextleaf Solutions.This transaction demonstrates the Company's capabilities as a total quality producer with validated quality assurance systems, multi-site operational coordination, and an export-ready platform.Global Medical Cannabis OpportunityInternational demand for export-ready, pharmaceutical grade product is transitioning from dried cannabis flower to include greater emphasis on derivative products. Nextleaf is advancing its Commercial Partners ProgramTM to enable increased access to medical cannabis through its formulated ingredients and branded product portfolio.The global medical cannabis market size reached USD 39.6 billion in 2025, and the market is projected to reach USD 74.3 billion by 2034 (6.9% growth)1."Nextleaf is uniquely positioned to meet rising global demand through patented extraction technology and industry-leading quality, setting the standard for processing cannabis at-scale," comments Emma Andrews, CEO.Built on the Company's foundation as a total quality producer, Nextleaf's Commercial Partners ProgramTM offers validated formulations, export-ready infrastructure, and a scalable operating model designed to support long-term, margin-focused growth for partners across domestic and international markets.The Company's high purity and full spectrum cannabinoid ingredients and dose-controlled drug delivery formats include cannabis softgels, vapes, and oils, through their flagship brand and Canadian market leaders, Glacial Gold. Ready-to-consume, discreet, and non-combustible products offer a more reliable, convenient and safe consumption experience for the enhanced confidence of patients and prescribers alike.OILS Commercial Partners ProgramTM, export ready softgel portfolio featuring Glacial Gold by Nextleaf LabsTo view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/5347/283825_ca4670e9a4fbb9ab_001full.jpgIMARC Medical Cannabis Report Nextleaf Delegation to Attend Australian Medicinal Cannabis Association (AMCA) ConferenceThe Australian Medicinal Cannabis Association will host their annual conference "United in Compassion' February 26-28, 2026, in Brisbane, Australia.Australia's medical cannabis market continues to demonstrate strong growth, supported by a robust regulatory framework, increasing patient adoption, and rising demand for consistent, pharmaceutical-grade formulations. As the market evolves, it has transitioned into a more structured and compliance-driven ecosystem where reliable supply, validated products, and operational discipline are increasingly valued by distributors and prescribers.CEO Emma Andrews will be attending the AMCA conference and is available for meetings in Sidney, Melbourne, and Brisbane. Australian-based medical cannabis resellers, distributors, and prospective international partners are encouraged to contact Andrews directly through LinkedIn, or through email info@nextleafsolutions.com.About Nextleaf Solutions Ltd.Nextleaf® is a Canadian, federally licensed cannabis processor and life science company, delivering a portfolio of high purity cannabinoid ingredients and branded derivative products at scale.As a total quality producer, Nextleaf maintains end-to-end controls and oversight across sourcing, extraction, distillation, formulation, and finished goods through a multi-patented, highly automated, closed-loop system. Nextleaf holds 19 U.S. patents and over 75 patents globally covering advanced cannabinoid processing, including extraction, distillation, and acetylation.Nextleaf's house of brands includes a range of value-driven and soft-premium offerings through category-leading flagship brand Glacial Gold, High Plains Cannabis, and recently launched Yard Cannabis. Distributed coast-to-coast across medical and recreational channels, with an emerging niche amongst wellness consumers, Nextleaf's portfolio includes GMP-compliant and export-ready pharma-grade ingredients and products.On behalf of the Board of Directors of the Company,
Emma Andrews, CEO Contact: investors@nextleafsolutions.com Follow Nextleaf Solutions on LinkedIn Learn More: www.nextleafsolutions.comNextleaf trades as OILS on the Canadian Securities Exchange, OILFF on the OTCQB Market in the United States, and L0MA on the Frankfurt Stock Exchange. Disclaimers and Disclosure Statements: Certain statements contained in this press release constitute "forward-looking statements" within the meaning of applicable securities laws. All statements other than statements of historical fact contained in this press release, including, without limitation, statements regarding the Company's anticipated delivery of its products to provincial markets across Canada and those regarding the Company's strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words "believe", "expect", "aim", "intend", "plan", "continue", "will", "may", "would", "anticipate", "estimate", "forecast", "predict", "project", "seek", "should" or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company's expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to the risk factors discussed in the Company's MD&A for the most recent fiscal period. Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law. The Canadian Securities Exchange has not reviewed or approved the contents of this press release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/283825
Original: Nextleaf Solutions Completes Initial Softgel Shipment to Australia and Announces Global Expansion of Commercial Partners Program(TM)

Nextleaf Reports Fiscal Year 2025 Financial PerformanceJanuary 28, 2026 4:30 PM
NewsfileVancouver, British Columbia--(Newsfile Corp. - January 28, 2026) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), a multi-patented life science company and Canadian cannabis processor, is pleased to report its financial results for the Fiscal Year (FY) 2025.For the twelve months ended September 30, 2025, the Company delivered a transformative performance, including a dramatic reduction in net loss, increased gross profit, and positive Adjusted EBITDA, reflecting continued progress toward sustainable profitability.Key Financial HighlightsGross Revenue of $14,955,459Net Revenue of $11,264,354 Operating expenses improved by 21% representing a reduction of $1,080,005 in expenses year over yearAnnual net loss dramatically reduced by 88.6% to $162,944, compared to $1,435,991 in FY 2024 Achieved positive EBITDA1 of $522,258, a significant reversal from the ($677,280) loss reported in the prior year Gross profit increased to $3,793,401 up from $3,742,561 in FY2024Operating Cash Flow: Generated positive cash flow from operations of $208,805, compared to a use of ($614,092) in the previous year[1] Non-IFRS or supplementary financial measure. See discussion in the Non-IFRS Financial Measures advisories section of this press release below and Management Discussion & Analysis.Financial PerformanceGross revenue was $14,955,459 compared to $16,567,537 in fiscal 2024, while the quality of the Company's earnings improved significantly. Annual gross profit rose to $3,793,401, and annual gross margins expanded from 23% to 25%. Performance was driven by a deliberate shift toward higher-margin products and improved supply chain efficiency. The Company streamlined its portfolio through targeted SKU rationalization, disciplined pricing, and continued brand innovation, while optimizing its product mix by prioritizing consumer packaged goods over bulk distillate sales. This shift supported higher gross margins.During Q4 FY25, cannabis distribution in British Columbia was temporarily disrupted due to labour action at the BCLDB, which affected order fulfilment and created short-term sales variability in the province. The impact was contained to BC and was partially offset by steady performance in other provincial markets."While working capital may fluctuate quarter to quarter, generating cash flow from operations remains a core priority. We are continuing to optimize our cash conversion cycle through improved receivables collection, disciplined inventory management, and controlled operating expenses. We will actively monitor liquidity and evaluate strategic financing options as needed to support growth and long-term sustainability," comments Sam Kassem, Nextleaf CFO.Commercial ExpansionFiscal 2025 revenue performance was driven by disciplined commercial execution, including a new brand launch, increased provincial listings, portfolio optimization, and geographic expansion. The Company successfully entered Québec with Glacial Gold branded oils and white-label extracts through strategic partnerships expanding its national footprint and revenue opportunities.Portfolio optimization validated the launch of Yard, a new recreational brand designed to address growing demand for premium extracts and next-generation hardware. Yard introduces a more playful brand identity while leveraging the Company's core manufacturing strengths, broadening appeal without diluting operational focus.During FY25, the Company launched over 20 new SKUs, bringing the active portfolio to 45 SKUs by year-end. The Company currently holds the largest national assortment of balanced, or high-CBD vape formulations (1:1 and 3:1), aligning product development with sustained consumer demand for wellness-forward, non-combustible formats under the Glacial Gold banner.The Company's best-selling products remain Glacial Gold THC 10 Softgels (50 and 100-pack), Balanced 10:10 Softgels (50 and 100-pack), and Max Strength CBD 200 Oil which underscore Nextleaf's leadership position within high-potency, ingestible extracts."Through the longevity of our core SKUs and consistent market performance over time, we have established a reputation for trustworthy quality, clean ingredients, transparent labeling, and reliable dosing. These foundational attributes support scalable brand growth and long-term commercial expansion," shares Emma Andrews, Nextleaf CEO.2026 OutlookThe Company has prioritized the following strategic initiatives for fiscal 2026:Pursue global export strategy with international resellers and commercial partnersCapital allocation towards organically grown biomass sourced in BC for bulk distillate processing and salesScaling up operations at Nextleaf Distribution FacilityOnboard national sales agency for expanded distribution and brand presence in underrepresented regions including Ontario, Manitoba, Saskatchewan, and across national key accounts.Full digital transformation through completed ERP integrationEstablish Yard as a profitable national brand, with expanded listings in all major marketsIncrease market share across all Glacial Gold SKUs and maintain national category leadership position in oils and softgelsAbout Nextleaf Solutions Ltd.Nextleaf® is a Canadian, federally licensed cannabis processor and life science company, delivering a portfolio of high purity cannabinoid ingredients and branded derivative products at scale.As a total quality producer, Nextleaf maintains end-to-end controls and oversight across sourcing, extraction, distillation, formulation, and finished goods through a multi-patented, highly automated, closed-loop system. Nextleaf holds 19 U.S. patents and over 75 patents globally covering advanced cannabinoid processing, including extraction, distillation, and acetylation.Nextleaf's house of brands includes a range of value-driven and soft-premium offerings through category-leading flagship brand Glacial Gold, High Plains Cannabis, and recently launched Yard Cannabis. Distributed coast-to-coast across medical and recreational channels, with an emerging niche amongst wellness consumers, Nextleaf's portfolio includes GMP-compliant and export-ready pharma-grade ingredients and products.On behalf of the Board of Directors of the Company,
Emma Andrews, CEO Contact: investors@nextleafsolutions.com
Follow Nextleaf Solutions on LinkedIn
Learn More: www.nextleafsolutions.comNextleaf trades as OILS on the Canadian Securities Exchange, OILFF on the OTCQB Market in the United States, and L0MA on the Frankfurt Stock Exchange. Disclaimers and Disclosure Statements: Certain statements contained in this press release constitute "forward-looking statements" within the meaning of applicable securities laws. All statements other than statements of historical fact contained in this press release, including, without limitation, statements regarding the Company's anticipated delivery of its products to provincial markets across Canada and those regarding the Company's strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words "believe", "expect", "aim", "intend", "plan", "continue", "will", "may", "would", "anticipate", "estimate", "forecast", "predict", "project", "seek", "should" or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company's expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to the risk factors discussed in the Company's MD&A for the most recent fiscal period. Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law. The Canadian Securities Exchange has not reviewed or approved the contents of this press release.Non-IFRS Financial MeasuresThis press release includes references to "Adjusted EBITDA", which are not defined under International Financial Reporting Standards (IFRS). The intent of these non-IFRS measures is to provide additional useful information to investors and analysts. These non-IFRS measures do not have a standardized meaning prescribed by IFRS and is therefore unlikely to be comparable to similar measures presented by other entities. As such, these non-IFRS measures should not be considered in isolation or used as a substitute for measures of performance prepared in accordance with IFRS. Adjusted EBITDA is calculated as EBITDA plus share-based compensation expense. Adjusted EBITDA is considered as a useful measure by management to understand the profitability of Nextleaf Solutions excluding the effects of certain non-operating items.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/281972
Original: Nextleaf Reports Fiscal Year 2025 Financial Performance

So hey are they still suppliers of distillate to BevCanna ?

Is your chart still in play or did it break down?

January 11th - Buy OILS



2 sessions later : Nice.




Super much in line with this :





2 sessions later :













Kind of / Sort of much like this : (similar sort of thang).......Altho here we're talkin' Lithium



7 sessions later ;









nowwhat 2021

NEXT DAY


















nowwhat

Quote : I can see this company being a pioneer.....The arrangement ? with BevCanna is huge ?
I wonder if they are still working with them....


https://www.nextleafsolutions.com/news/nextleaf-solutions-granted-50th-patent-and-provides-commercial-update/

Up 13%



Up 13%

The agreement with BevCanna just as Canada's cannabis laws are changing is huge! I can see this company being a pioneer in the commercialized CBD market

MONO; DO you believe that truly WATER-SOLUBLE CBD will be the not to distant future of CBD??? I am reading all I can on SPROUTLY symbol SRUTF

which will produce a truly water-soluble CBD...quite time consuming...

Your thoughts would be GREATLY APPRECIATED>>>


CharlieB

IF there products are NOT water-soluble which should be the next true wave

then why invest in them???

CharlieB

Sounds similar to Valens Sorse technology.

Interesting new player.

https://www.nextleafsolutions.com/

https://www.newswire.ca/news-releases/nextleaf-solutions-commences-trading-on-the-cse-under-ticker-oils--807292758.html

“Nextleaf’s focus on ethanol allows the company to effectively process large amounts of biomass, leading to lower CAPEX and operating costs, and higher efficiencies than its direct competitors.” https://t.co/ZkN1oPH45v $OILS #soiltooil #maximizevalue #extracts #concentrates pic.twitter.com/8m7xeXtQlz— Nextleaf Solutions (@nextleaf_oils) April 18, 2019

And on the fourth day the father of fathers created oils..Let there be light.